1. Aminoglycoside antibiotics as first-line treatment of acute appendicitis and cholecystitisLučka Šetinc, Tadeja Pintar, Aleksandar Zafirovski, Uroš Godnov, Bojana Beović, 2025, original scientific article Abstract: We analyzed the efficacy and safety of aminoglycosides in a retrospective study of 415 patients with acute appendicitis and 277 patients with acute cholecystitis. The following variables increased the incidence of postoperative complications, defined as surgical site infection, recurrent intraabdominal infection, non-infectious post-operative complication, or death: age (p = 0.016 and 0.011), kidney disease (p = 0.019 and <0.001), and ASA Score (p < 0.001). The type of antibiotic therapy did not have a statistically significant effect on the incidence of postoperative complications in patients with acute appendicitis and cholecystitis (p = 0.561 and 0.547, respectively). A linear regression model showed a higher complication rate in patients with kidney disease (p = 0.014) and neoplasms (p = 0.013); the type of antibiotic therapy did not have a significant effect on the outcome (p = 0.765). There was no statistically significant difference in the post-treatment levels of creatinine in patients treated with aminoglycosides (gentamicin 3 mg/kg once daily) and in those who received other antibiotics (p = 0.75). Keywords: aminoglycoside, antibiotics, antimicrobial resistance, intraabdominal infection, nephrotoxicity, risk factors Published in DiRROS: 26.03.2026; Views: 155; Downloads: 97
Full text (1,30 MB) This document has many files! More... |
2. Microbial DNA extraction of high-host content and low biomass samples : optimized protocol for nasopharynx metagenomic studiesPolona Rajar, Achal Dhariwal, Gabriela Salvadori, Roger Junges, Heidi Aarø Åmdal, Dag Berild, Drude Fugelseth, Ola Didrik Saugstad, 2022, original scientific article Abstract: Introduction: Low microbial biomass and high human DNA content in nasopharyngeal aspirate samples hinder comprehensive characterization of microbiota and resistome. We obtained samples from premature infants, a group with increased risk of developing respiratory disorders and infections, and consequently frequent exposure to antibiotics. Our aim was to devise an optimal protocol for handling nasopharyngeal aspirate samples from premature infants, focusing on host DNA depletion and microbiome and resistome characterization. Methods: Three depletion and three DNA extraction protocols were compared, using RT-PCR and whole metagenome sequencing to determine the efficiency of human DNA removal, taxonomic profiling and assignment of antibiotic resistance genes. Protocols were tested using mock communities, as well as pooled and individual patient samples. Results: The only extraction protocol to retrieve the expected DNA yield from mock community samples was based on a lytic method to improve Gram positive recovery (MasterPure™). Host DNA content in non-depleted aliquots from pooled patient samples was 99%. Only samples depleted with MolYsis™ showed satisfactory, but varied reduction in host DNA content, in both pooled and individual patient samples, allowing for microbiome and resistome characterisation (host DNA content from 15% to 98%). Other depletion protocols either retrieved too low total DNA yields, preventing further analysis, or failed to reduce host DNA content. By using Mol_MasterPure protocol on aliquots from pooled patient samples, we increased the number of bacterial reads by 7.6 to 1,725.8-fold compared to non-depleted reference samples. PCR results were indicative of achieved microbial enrichment. Individual patient samples processed with Mol_MasterPure protocol varied greatly in total DNA yield, host DNA content (from 40% to 98%), species and antibiotic resistance gene richness. Discussion: Despite high human DNA and low microbial biomass content in nasopharynx aspirates of preterm infants, we were able to reduce host DNA content to levels compatible with downstream shotgun metagenomic analysis, including bacterial species identification and coverage of antibiotic resistance genes. Whole metagenomic sequencing of microbes colonizing the nasopharynx may contribute to explaining the possible role of airway microbiota in respiratory conditions and reveal carriage of antibiotic resistance genes. Keywords: antimicrobial resistance, host DNA depletion, low biomass, microbiome, premature infant, resistome, respiratory microbiome, whole metagenomic sequencing Published in DiRROS: 25.02.2026; Views: 298; Downloads: 191
Full text (3,67 MB) This document has many files! More... |
3. A time series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 epidemics : a multicentre cross-national ecological study on behalf of QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics study projectMarianna Meschiari, José María López Lozano, Filippo Medioli, Erica Bacca, Mario Sarti, Mateja Pirš, Sergeja Gregorčič, Bojana Beović, 2025, original scientific article Abstract: Objectives: We aimed to assess the impact of COVID-19 on antibiotic consumption (AMC) and antimicrobial resistance (AMR) in the new epidemiological scenario from a cross-national perspective. Methods: A quasi-experimental retrospective multicentre ecological study was conducted to explore the impact of COVID-19 on AMC and AMR using routinely generated retrospective time series data. This study included nine Healthcare University Hospitals from Europe and Israel on behalf QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics project. Total effects were defined as the difference between the pre-COVID-19 period (ranging from January 2015 or January 2016 to February 2020) and during the COVID-19 pandemic period (March 2020 to July 2021 or December 2021). The outcomes were incidence density (ID) of carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Klebsiella pneumoniae, extended-spectrum beta-lactamase-producing Escherichia coli, vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus, carbapenem-resistant Pseudomonas aeruginosa and Clostridioides difficile, as monthly isolates per 1000 patient days and the monthly AMC ranked according to the Access, Watch, and Reserve WHO classification system. Results: We assessed 15.9 million total hospital bed days, 315 736 COVID-19 bed days, 52 557 monthly bacterial isolates, and 461 739 monthly antimicrobial defined daily doses. The COVID-19 pandemic had a significant impact on the consumption of overall hospital antibiotics combined in all centres except two. Prescriptions for piperacillin/tazobactam, glycopeptides, and ceftazidime/avibactam increased, whereas third-generation cephalosporins, macrolides, and fluoroquinolones returned to pre-pandemic levels after an initial surge, in all centres. A positive relationship between the pandemic intensity and VRE ID was observed in 6 of 9 (66%) centres followed by methicillin-resistant S. aureus-ID and carbapenemresistant P. aeruginosa-ID 3 of 4 (44%) for both. A negative relationship was found for extendedspectrum beta-lactamase-producing E. coli ID. Discussion: The COVID-19 pandemic was associated with higher usage of broad-spectrum antibiotics and higher incidence of multidrug-resistant bacteria, with great variability by countries. These results could support international action plans that embed AMR as a priority in the post-COVID-19 era. Keywords: antibiotic consumption, antimicrobial resistance, COVID-19, multicentre, multi-drug resistant organisms, non-linear time series, thresholds Published in DiRROS: 23.02.2026; Views: 295; Downloads: 173
Full text (6,00 MB) This document has many files! More... |
4. Global health at crossroads : uniting together to overcome challenges, restore trust and advance priorities for a sustainable futureMassimo Sartelli, Elias Mossialos, Federico Coccolini, Ib Jammer, Francesco M. Labricciosa, Philip S. Barie, Walter L. Biffl, Ziad A. Memish, Markus Maeurer, 2025, other scientific articles Abstract: The world is currently facing an unprecedented convergence of crises that threaten the core pillars of public health, scientific integrity, and social stability. These challenges are profoundly interconnected and have the potential to exacerbate global inequalities, jeopardize health security, and undermine the progress achieved through decades of international collaboration. Our viewpoint declaration, developed by 366 healthcare workers and scientists from 119 countries across six continents, highlights the urgent need for global solidarity and collective action to address these interconnected global health challenges. As healthcare workers and scientists, we must prioritize the protection of scientific integrity, combat political interference, and restore public trust in the scientific process. This will require a commitment to transparency, ethical responsibility, and evidence-based decision-making that can stand strong in the face of political and social adversity. The COVID-19 pandemic has underscored the critical importance of resilient healthcare systems, emphasizing that preparedness, capacity building and coherent leadership and coordination are essential for future global health crises. In addition, our call for a One Health approach, acknowledging the intricate relationship between human, animal, and environmental health, has never been more pressing, especially as zoonotic diseases and antimicrobial resistance spread across borders. As we confront ongoing wars, environmental destruction, and global persistent health inequalities, it is only through unity, solidarity, collaboration, and innovation that we hope to build a healthier, more equitable world. Together, we must ensure that science and medicine remain a force for good, capable of addressing both the immediate and long-term needs and challenges facing our shared future. Keywords: antimicrobial resistance, artificial intelligence, climate change, global health, healthcare systems, infectious diseases, misinformation, one health, public health, scientific research Published in DiRROS: 08.01.2026; Views: 472; Downloads: 211
Full text (1,02 MB) This document has many files! More... |
5. Nanoagrosomes : future prospects in the management of drug resistance for sustainable agricultureK. Manju, H.K. Ranjini, S. Niranjan Raj, Raghuraj S. Chouhan, Syed Baker, 2023, review article Abstract: Agriculture plays a crucial role in sustaining the global population with food safety and security. The inadequacy of current agrochemicals in effectively controlling microbial infestations necessitates immediate attention. The over usage of agrochemicals has posed significant threat to agriculture by hampering the crop productivity, increased disease outbreaks and spread resistant microorganisms. This review addresses the pressing issue of drug-resistant microbial pathogens and their detrimental impact on the agricultural system. The use of nanoagrosomes has gained significant attention as a potential solution for combating drug-resistant pathogens due to their unique physicochemical properties, which can be tailored to target specific activities. A diverse of nanoagrosomes is widely practiced to attenuate specific roles which has been outline in the review. It also shed light on their effectiveness in combating drug-resistant pathogens and their role in promoting agricultural sustainability by expanding scientific understanding of nanoagrosomes as a future prospect for management of drug resistance. Keywords: nanoagrosomes, agriculture, phytopatogens, antimicrobial resistance Published in DiRROS: 16.12.2025; Views: 508; Downloads: 238
Full text (2,73 MB) This document has many files! More... |
6. Nanovaccines to combat drug resistance : the next-generation immunisationK. Manju, S. Niranjan Raj, Raghuraj S. Chouhan, Syed Baker, 2023, review article Abstract: Background. The present review envisages the role of nanovaccines to combat the global challenges of antimicrobial resistance. Nanovaccines are a novel formulation comprised of nanomaterials coupled with an immunogenic component to elicit the immune response and provide protection against the desired infectious disease. The nanovaccines with unique physicochemical properties can be more efficient against targeting the desired tissues in the body, aids in prolong circulation to promote antigen-presenting cells to act upon the target antigens. Main content. The present review envisages the development of nanovaccines against antimicrobial-resistant pathogens. The use of nanovaccines can exhibit potent antigenicity with prolonged retention and controlled release to induce both cell- and antibody-mediated responses. Nanovaccines usage is still in the early stages and can be next-generation immunisation for prophylactic and therapeutic efficiency. The future development of nanovaccines against multi-drug-resistant pathogens can explore new avenues. Based on these facts, the present review is designed from the previously reported scientific studies and compiled with the fact that nanovaccines can revolutionise vaccine strategies. The articles were extracted from reputed databases like PubMed, Scopus, and ESCI. The size and conjugating chemistry of nanomaterials can be beneficial in developing novel multi-nanovaccine formulations that can target pools of antimicrobial resistance mechanisms. Conclusion. Overall, the nanovaccines can form one of the best effective modes of targeting multi-drug-resistant pathogens. The nanovaccines can stimulate the innate immune response and generate effective immune-therapeutic novel formulation against infectious pathogens. Based on these facts and considerations, the present article makes an alarming call to develop nanovaccines to counter multi-drug resistance. Keywords: nanovaccines, antimicrobial drug resistance, nanomaterials, HIV, WHO Published in DiRROS: 16.12.2025; Views: 430; Downloads: 236
Full text (1,39 MB) This document has many files! More... |
7. Digital PCR-based genotyping: a precision approach to HCMV drug resistanceMojca Milavec, Tašja Cvelbar, Alexandra Bogožalec Košir, 2025, independent scientific component part or a chapter in a monograph Abstract: The genotyping workflow described uses digital PCR (dPCR) to detect and quantify drug resistance mutations in human cytomegalovirus (HCMV). The method focuses on the detection and quantification of three common mutations in the UL97 gene at codons 460, 594, and 595, which are responsible for the majority of ganciclovir-resistant clinical isolates. The dPCR approach offers high sensitivity and accuracy, making it suitable for routine testing as well as a reference measurement procedure for external quality assessment schemes. The workflow includes several key steps: DNA isolation, preparation of the dPCR reaction mixture, partitioning, thermocycling, and data analysis. This method improves the detection capabilities of HCMV drug resistance and provides a robust and efficient tool for clinical and research applications. Keywords: digital PCR, human cytomegalovirus, antimicrobial drug resistance, mutations Published in DiRROS: 25.09.2025; Views: 476; Downloads: 96
Full text (916,86 KB) This document has many files! More... |
8. Jellyfish blooms : an overlooked hotspot and potential vector for the transmission of antimicrobial resistance in marine environmentsAlan X. Elena, Neža Orel, Peiju Fang, Gerhard J. Herndl, Thomas U. Berendonk, Tinkara Tinta, Uli Klümper, 2025, original scientific article Abstract: Gelatinous zooplankton (GZ) represents an important component of marine food webs, capable of generating massive blooms with severe environmental impact. When these blooms collapse, considerable amounts of organic matter (GZ-OM) either sink to the seafloor or can be introduced into the ocean’s interior, promoting bacterial growth and providing a colonizable surface for microbial interactions. We hypothesized that GZ-OM is an overlooked marine hotspot for transmitting antimicrobial resistance genes (ARGs). To test this, we first re-analyzed metagenomes from two previous studies that experimentally evolved marine microbial communities in the presence and absence of OM from Aurelia aurita and Mnemiopsis leidyi recovered from bloom events and thereafter performed additional time-resolved GZ-OM degradation experiments to improve sample size and statistical power of our analysis. We analyzed these communities for composition, ARG, and mobile genetic element (MGE) content. Communities exposed to GZ-OM displayed up to fourfold increased relative ARG and up to 10-fold increased MGE abundance per 16S rRNA gene copy compared to the controls. This pattern was consistent across ARG and MGE classes and independent of the GZ species, indicating that nutrient influx and colonizable surfaces drive these changes. Potential ARG carriers included genera containing potential pathogens raising concerns of ARG transfer to pathogenic strains. Vibrio was pinpointed as a key player associated with elevated ARGs and MGEs. Whole-genome sequencing of a Vibrio isolate revealed the genetic capability for ARG mobilization and transfer. This study establishes the first link between two emerging issues of marine coastal zones, jellyfish blooms and ARG spread, both likely increasing with future ocean change. Hence, jellyfish blooms are a quintessential “One Health” issue where decreasing environmental health directly impacts human health. Keywords: gelatinous zooplankton, antimicrobial resistance genes, organic matter, microbial interactions, vibrio Published in DiRROS: 20.02.2025; Views: 1017; Downloads: 563
Full text (5,22 MB) This document has many files! More... |
9. Digital PCR method for detection and quantification of specific antimicrobial drug-resistance mutations in human cytomegalovirusAlexandra Bogožalec Košir, Tašja Cvelbar, Martin Kammel, Hans-Peter Grunert, Heinz Zeichhardt, Mojca Milavec, 2020, original scientific article Abstract: Antimicrobial drug resistance is one of the biggest threats to human health worldwide. Timely detection and quantification of infectious agents and their susceptibility to antimicrobial drugs are crucial for efficient management of resistance to antiviral drugs. In clinical settings, viral drug resistance is most often associated with prolonged treatment of chronic infections, and assessed by genotyping methods; e.g., sequencing and PCR. These approaches have limitations: sequencing can be expensive and does not provide quantification; and qPCR quantification is hampered by a lack of reference materials for standard curves. In recent years, digital PCR has been introduced, which provides absolute quantification without the need for reference materials for standard curves. Using digital PCR, we have developed a rapid, sensitive and accurate method for genotyping and quantification of the most prevalent mutations that cause human cytomegalovirus resistance to ganciclovir. Keywords: digital PCR, antimicrobial-drug resistance, HCMV, polymerase chain reaction, viruses Published in DiRROS: 22.07.2024; Views: 1318; Downloads: 659
Full text (5,71 MB) This document has many files! More... |